FDA approves first-of-its-kind antibiotic from GSK
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of GSK plc to Contact the Firm Today!
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
GSK pushes UK government to give more access to health data, Bloomberg says
GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...
New York Post6d
FDA greenlights GSK’s drug for UTIs in women and girls
The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...
Bloomberg L.P.4d
GSK Wants UK to Open Up Health Records to Boost Drug Development
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to accelerate drug development and halt the nation’s slide down global life ...
Yahoo Finance5d
Jim Cramer Says ‘Buy and Put Away’ GSK (GSK) for Its 4% Yield
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other stocks that Jim Cramer discussed. On Tuesday, Jim Cramer, host of Mad Money, defended the growing wave ...
pharmaphorum1d
GSK says $2.2bn settlement resolves most Zantac litigation
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...
pharmaphorum1d
GSK bags breakthrough status for bone cancer drug
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...